These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8948516

  • 1. Effect of modulators of tyrosine kinase activity on agonist-induced contraction in the rat pulmonary vascular smooth muscle.
    Savineau JP, Gonzalez De La Fuente P, Marthan R.
    Pulm Pharmacol; 1996 Jun; 9(3):189-95. PubMed ID: 8948516
    [Abstract] [Full Text] [Related]

  • 2. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase.
    Duarte J, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J.
    Eur J Pharmacol; 1997 Oct 29; 338(1):25-33. PubMed ID: 9408000
    [Abstract] [Full Text] [Related]

  • 3. Control of pulmonary vascular smooth muscle tone by sarcoplasmic reticulum Ca2+ pump blockers: thapsigargin and cyclopiazonic acid.
    Gonzalez De La Fuente P, Savineau JP, Marthan R.
    Pflugers Arch; 1995 Mar 29; 429(5):617-24. PubMed ID: 7792139
    [Abstract] [Full Text] [Related]

  • 4. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW, Florian JA, Monroe KM.
    J Pharmacol Exp Ther; 1998 Sep 29; 286(3):1431-8. PubMed ID: 9732408
    [Abstract] [Full Text] [Related]

  • 5. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity.
    Petrescu G, Costuleanu M, Slatineanu SM, Costuleanu N, Foia L, Costuleanu A.
    J Renin Angiotensin Aldosterone Syst; 2001 Sep 29; 2(3):180-7. PubMed ID: 11881120
    [Abstract] [Full Text] [Related]

  • 6. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle.
    Abebe W, Agrawal DK.
    J Cardiovasc Pharmacol; 1995 Jul 29; 26(1):153-9. PubMed ID: 7564357
    [Abstract] [Full Text] [Related]

  • 7. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle.
    Jin N, Siddiqui RA, English D, Rhoades RA.
    Am J Physiol; 1996 Oct 29; 271(4 Pt 2):H1348-55. PubMed ID: 8897927
    [Abstract] [Full Text] [Related]

  • 8. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction.
    Filipeanu CM, Brailoiu E, Huhurez G, Slatineanu S, Baltatu O, Branisteanu DD.
    Eur J Pharmacol; 1995 Jul 25; 281(1):29-35. PubMed ID: 8566113
    [Abstract] [Full Text] [Related]

  • 9. A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta.
    Jinsi A, Paradise J, Deth RC.
    Eur J Pharmacol; 1996 Apr 29; 302(1-3):183-90. PubMed ID: 8791006
    [Abstract] [Full Text] [Related]

  • 10. Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery.
    Savineau JP, Marthan R.
    Pulm Pharmacol; 1993 Mar 29; 6(1):41-8. PubMed ID: 8477154
    [Abstract] [Full Text] [Related]

  • 11. Wine polyphenols modulate calcium handling in rat aorta: involvement of nitric oxide pathway.
    Diebolt M, Andriantsitohaina R.
    Fundam Clin Pharmacol; 2002 Aug 29; 16(4):289-96. PubMed ID: 12570017
    [Abstract] [Full Text] [Related]

  • 12. Role of tyrosine kinase on Ca2+ entry and refilling of agonist-sensitive Ca2+ stores in vascular smooth muscles.
    Low AM.
    Can J Physiol Pharmacol; 1996 Mar 29; 74(3):298-304. PubMed ID: 8773410
    [Abstract] [Full Text] [Related]

  • 13. Activation of tyrosine kinases in H2O2-induced contraction in pulmonary artery.
    Jin N, Rhoades RA.
    Am J Physiol; 1997 Jun 29; 272(6 Pt 2):H2686-92. PubMed ID: 9227547
    [Abstract] [Full Text] [Related]

  • 14. Effects of genistein and staurosporine on angiotensin II-induced DNA synthesis, protein synthesis and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Hanada M, Saito E, Kambe T, Hagiwara Y, Kubo T.
    Biol Pharm Bull; 1998 Oct 29; 21(10):1045-9. PubMed ID: 9821807
    [Abstract] [Full Text] [Related]

  • 15. Regulation of vascular and gastric smooth muscle contractility by pervanadate.
    Laniyonu A, Saifeddine M, Ahmad S, Hollenberg MD.
    Br J Pharmacol; 1994 Oct 29; 113(2):403-10. PubMed ID: 7530569
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor-alpha impairs endothelium-dependent relaxation of rat renal arteries, independent of tyrosine kinase.
    Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P.
    Shock; 2002 May 29; 17(5):394-8. PubMed ID: 12022760
    [Abstract] [Full Text] [Related]

  • 17. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.
    Ghisdal P, Vandenberg G, Morel N.
    J Physiol; 2003 Sep 15; 551(Pt 3):855-67. PubMed ID: 12853654
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists.
    Laniyonu AA, Saifeddine M, Yang SG, Hollenberg MD.
    Can J Physiol Pharmacol; 1994 Sep 15; 72(9):1075-85. PubMed ID: 7842390
    [Abstract] [Full Text] [Related]

  • 19. Modulation of Ca2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation.
    Steusloff A, Paul E, Semenchuk LA, Di Salvo J, Pfitzer G.
    Arch Biochem Biophys; 1995 Jul 10; 320(2):236-42. PubMed ID: 7625829
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine kinase is involved in angiotensin II-stimulated phospholipase D activation in aortic smooth muscle cells: function of Ca2+ influx.
    Suzuki A, Shinoda J, Oiso Y, Kozawa O.
    Atherosclerosis; 1996 Mar 10; 121(1):119-27. PubMed ID: 8678916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.